This is the authors' abstract. We don't add key points for this paper.
Metabolic imaging with FDG PET/CT proved useful in patients where OC recurrence was suspected, even when the value of tumor marker CA125 was in a normal range. A positive PET/CT scan and the presence of peritoneum recurrence at PET were associated with a poor prognosis after approximately 30 months.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Evangelista et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: